Cardiovascular Health Study

Cardiovascular Health Study
Name	Cardiovascular Health Study
Acronym	CHS
Established	1988
Location	United States
Field	Epidemiology
Participants	Older adults
Duration	Longitudinal cohort

Cardiovascular Health Study The Cardiovascular Health Study was a longitudinal cohort study of older adults in the United States that investigated determinants of cardiovascular disease, disability, and mortality. It enrolled community-dwelling older men and women and generated influential data used by clinicians, epidemiologists, and policymakers worldwide. The study's extensive datasets have been analyzed alongside research from institutions and investigators associated with major cohorts, consortia, and public health agencies.

Background

The initiative emerged during a period of expanding cohort research led by institutions such as the National Institutes of Health, Johns Hopkins University, Harvard University, Stanford University, and University of California, San Francisco. Funding and oversight involved agencies and programs including the National Heart, Lung, and Blood Institute, Centers for Disease Control and Prevention, and collaborations with academic centers like University of Pittsburgh and Wake Forest University. Similar large-scale efforts contemporaneous with CHS included the Framingham Heart Study, the Atherosclerosis Risk in Communities Study, the Nurses' Health Study, and the Women’s Health Initiative, reflecting a broader shift in epidemiology exemplified by work at Columbia University, Yale University, and Michigan State University.

Study Design and Methods

CHS used longitudinal observational methods with baseline recruitment and serial follow-up visits, comparable in design to cohorts such as the Rotterdam Study, the Baltimore Longitudinal Study of Aging, and the Multi-Ethnic Study of Atherosclerosis. Standardized examinations drew on protocols from laboratories at Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, and diagnostic imaging advances pioneered at University of Pennsylvania. Data collection included clinical exams, laboratory assays, electrocardiography, echocardiography, and carotid ultrasonography, with analytic frameworks influenced by biostatistical groups at University of Washington and University of North Carolina at Chapel Hill. Linkage to Medicare claims and death registries paralleled data integration strategies used by researchers at Duke University Medical Center and Brown University.

Participant Characteristics

Participants were community-dwelling older adults recruited from multiple field centers affiliated with institutions such as University of California, Davis, University of California, Berkeley, University of Vermont, and University of Iowa. The cohort included men and women with diverse clinical profiles, some of whom had comorbidities commonly studied at centers like Northwestern University, Columbia-Presbyterian Medical Center, and Beth Israel Deaconess Medical Center. Baseline characteristics—age distribution, sex, race/ethnicity, smoking history, hypertension prevalence—were described using approaches similar to analyses from Boston University, University of Minnesota, and Indiana University School of Medicine.

Major Findings

Analyses from the study produced seminal findings about risk factors for incident coronary heart disease, stroke, heart failure, and atrial fibrillation, informing clinical questions also examined in the Framingham Heart Study and the INTERHEART Study. Key publications linked subclinical atherosclerosis measured by carotid intima-media thickness and coronary calcification to cardiovascular events, results consonant with imaging work at Mount Sinai Hospital, Royal Brompton Hospital, and Karolinska Institutet. The cohort clarified relations of hypertension and pulse pressure with outcomes, echoing randomized-trial evidence from Systolic Hypertension in the Elderly Program and meta-analyses from Cochrane Collaboration. Investigations tied inflammation markers like C-reactive protein to incident disease, paralleling biomarker research at Imperial College London, University of Oxford, and University College London. The study also reported associations of frailty, gait speed, and cognitive decline with cardiovascular endpoints, themes pursued at University of California, Los Angeles, University of Chicago, and Columbia University Medical Center.

Public Health and Clinical Impact

Findings influenced guidelines and practitioner behavior reflected in recommendations from bodies such as the American Heart Association, American College of Cardiology, and professional societies at European Society of Cardiology. Data were used to refine risk prediction models analogous to work from Framingham Heart Study investigators and to inform preventive strategies promoted by World Health Organization initiatives and national programs at Centers for Medicare & Medicaid Services. CHS-derived evidence underpinned policy discussions involving agencies like the Department of Health and Human Services and academic-policy interfaces at Johns Hopkins Bloomberg School of Public Health and London School of Hygiene & Tropical Medicine.

Limitations and Criticisms

Critiques paralleled those leveled at other cohort studies such as the Framingham Heart Study and the Nurses' Health Study, including concerns about generalizability beyond enrolled communities represented by field centers affiliated with University of Pittsburgh Medical Center and University of Colorado School of Medicine. Issues discussed in methodological literature at Stanford University School of Medicine and Yale School of Public Health included residual confounding, measurement error, and cohort attrition over extended follow-up, similar to debates surrounding the Baltimore Longitudinal Study of Aging and the Rotterdam Study. The evolving nature of diagnostic criteria and therapies—reflected in changing practice at institutions like Massachusetts General Hospital and Mayo Clinic—also complicated interpretation of long-term secular trends.

Category:Epidemiology studies